Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.01
-0.06-0.31%
At close: Dec 15, 4:00 PM EST
$19.25
0.241.26%
After Hours: 4:20 PM EST
Comments
Loading...
Nurix Therapeutics Analyst Ratings and Price Targets | NASDAQ:NRIX | Benzinga
Nurix Therapeutics Inc has a consensus price target of $28.81 based on the ratings of 21 analysts. The high is $41 issued by Jefferies on October 11, 2024. The low is $15 issued by Morgan Stanley on October 14, 2025. The 3 most-recent analyst ratings were released by Mizuho, HC Wainwright & Co., and BTIG on December 10, 2025, December 10, 2025, and December 9, 2025, respectively. With an average price target of $30.33 between Mizuho, HC Wainwright & Co., and BTIG, there's an implied 57.58% upside for Nurix Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
HC Wainwright & Co.
BTIG
Needham
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Nurix Therapeutics
FAQ
What is the target price for Nurix Therapeutics (NRIX) stock?
The latest price target for Nurix Therapeutics (NASDAQ:NRIX) was reported by Mizuho on December 10, 2025. The analyst firm set a price target for $30.00 expecting NRIX to rise to within 12 months (a possible 55.84% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nurix Therapeutics (NRIX)?
The latest analyst rating for Nurix Therapeutics (NASDAQ:NRIX) was provided by Mizuho, and Nurix Therapeutics maintained their outperform rating.
When was the last upgrade for Nurix Therapeutics (NRIX)?
There is no last upgrade for Nurix Therapeutics
When was the last downgrade for Nurix Therapeutics (NRIX)?
There is no last downgrade for Nurix Therapeutics.
When is the next analyst rating going to be posted or updated for Nurix Therapeutics (NRIX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nurix Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nurix Therapeutics was filed on December 10, 2025 so you should expect the next rating to be made available sometime around December 10, 2026.
Is the Analyst Rating Nurix Therapeutics (NRIX) correct?
While ratings are subjective and will change, the latest Nurix Therapeutics (NRIX) rating was a maintained with a price target of $24.00 to $30.00. The current price Nurix Therapeutics (NRIX) is trading at is $19.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
